TopPodcast.com
Menu
  • Home
  • Top Charts
  • Top Networks
  • Top Apps
  • Top Independents
  • Top Podfluencers
  • Top Picks
    • Top Business Podcasts
    • Top True Crime Podcasts
    • Top Finance Podcasts
    • Top Comedy Podcasts
    • Top Music Podcasts
    • Top Womens Podcasts
    • Top Kids Podcasts
    • Top Sports Podcasts
    • Top News Podcasts
    • Top Tech Podcasts
    • Top Crypto Podcasts
    • Top Entrepreneurial Podcasts
    • Top Fantasy Sports Podcasts
    • Top Political Podcasts
    • Top Science Podcasts
    • Top Self Help Podcasts
    • Top Sports Betting Podcasts
    • Top Stocks Podcasts
  • Podcast News
  • About Us
  • Podcast Advertising
  • Contact
Not in our directory?
Add Show Here
Podcast Equipment
Center

toppodcastlogoOur TOPPODCAST Picks

  • Comedy
  • Crypto
  • Sports
  • News
  • Politics
  • True Crime
  • Business
  • Finance

Follow Us

toppodcastlogoStay Connected

    View Top 200 Chart
    Back to Rankings Page
    Health & Fitness

    Journal of Clinical Oncology (JCO) Podcast

    The Journal of Clinical Oncology Podcast presents analyses and discussions centered on the latest findings published in ASCO’s flagship Journal of Clinical Oncology. Host Dr. Davide Soldato facilitates interviews and scholarly discourse on the most impactful published findings. The Journal of Clinical Oncology Podcast is the trusted resource that empowers you to integrate cutting-edge evidence into clinical practice.

    The year’s fellows interview authors and summarize the top Journal of Clinical Oncology articles in the series, JCO Article Insights.

    Advertise

    Copyright: © Copyright by the American Society of Clinical Oncology

    • Apple Podcasts
    • Google Play
    • Spotify

    Latest Episodes:
    Long Term Follow-up of NSABP B-31: How Well Can We Predict Cardiac Toxicity with Trastuzumab? Nov 16, 2012
    Show notes

    Seven year follow up of B-31 demonstrates a striking and reassuring lack of longer-term cardiac events.


    More Adjuvant Chemotherapy is Not Always Better Nov 16, 2012
    Show notes

    More adjuvant chemotherapy is not always better for early breast cancer patients - Discussion and consequence for clinical practice.


    Hodgkin Lymphoma: Protecting the Victims of Our Success Nov 13, 2012
    Show notes

    The podcast reviews the evolution of staging and treatment of Hodgkin lymphoma, reducing the toxicities and torture while maintaining a high level of cure.


    Beyond the Plasma Cell: Proteasome Inhibition in Acute Myelogenous Leukemia Nov 02, 2012
    Show notes

    In this podcast, Attar and colleagues explore whether patients aged 60-75 who enter remission with bortezomib added to standard anthracycline plus cytarabine chemotherapy during induction can be safely treated with intermediate dose cytarabine along with dose escalating bortezomib during consolidation. This regimen was tolerated at the highest dose of bortezomib tested, 1.3 mg/m2, and further randomized studies of this regimen will be planned.


    Breast Brachytherapy in the United States: Increasing Use Despite Increased Complication Rates Nov 01, 2012
    Show notes

    This podcast will review a JCO article showing that the use of breast brachytherapy as a method of delivering partial breast radiation after breast conserving surgery was associated with higher rates of complications than the conventional approach of whole breast radiation.


    Referral Practices to Palliative Care Among Canadian Oncologists Nov 01, 2012
    Show notes

    This Podcast provides observations and commentary about referral practices of oncologists to specialized palliative care.


    Clinical Utility of Screening Tests in Asymptomatic Long-Term Childhood Cancer Survivors Nov 01, 2012
    Show notes

    This podcast characterizes the clinical utility of the screening tests recommended by the Children's Oncology Group in the care of long-term survivors.


    Is Lymphatic Mapping Ready for Clinical Use in the Treatment of Squamous Vulvar Cancer? Oct 30, 2012
    Show notes

    Publication of a large collaborative group trial appears to definitively demonstrate the safety of sentinel lymph node biopsy as replacement for inguinal-femoral lymphadenectomy, or does it?


    Rituximab Maintenance Therapy After Autologous Stem Cell Transplantation: Final Analysis of the CORAL Trial Oct 23, 2012
    Show notes

    In this podcast, results of a randomized phase III clinical trial evaluating the use of Rituximab maintenance therapy following autologous stem cell transplantation in patients with relapsed diffuse large B cell lymphoma are summarized. The results demonstrate that Rituximab maintenance therapy does not result in improved event free or overall survival in this patient population.


    Informed Consent for Pediatric Phase I Cancer Trials: An End-of-Life Decision Oct 15, 2012
    Show notes

    Melissa Cousino and colleagues found that few parents understand the scientific purpose of phase I pediatric clinical trials.


    Previous 1 37 38 39 40 41 47 Next

    Related Podcasts

    Fresh Air

    1

    Fresh Air Arts
    Twenty Thousand Hertz

    2

    Twenty Thousand Hertz Arts
    The Black Tapes

    3

    The Black Tapes Arts
    Snap Judgment

    4

    Snap Judgment Arts
    Here’s The Thing with Alec Baldwin

    5

    Here’s The Thing with Alec Baldwin Arts
    The NoSleep Podcast – Creative Reason Media Inc.

    6

    The NoSleep Podcast – Creative Reason Media Inc. Arts
    footer-logo

    Contact Us

    Toll Free: 844-670-7747

    Links

    • Home
    • Top Charts
    • Networks
    • Apps
    • Independents Podcasts
    • Podcast Advertising
    • Podcast News
    • Contact Us
    • About Us
    • Analytics & Insights

    Stay Connected

      Privacy, Terms of Use & Our Code of Ethics Protecting Content Creators Copyrights